ASTH Stock Overview
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 5/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Narratives bring a range of perspectives from our community.
Astrana Health, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$33.70 |
52 Week High | US$63.20 |
52 Week Low | US$33.44 |
Beta | 1.14 |
1 Month Change | -19.97% |
3 Month Change | -40.91% |
1 Year Change | -11.15% |
3 Year Change | -52.43% |
5 Year Change | 80.70% |
Change since IPO | 210.89% |
Recent News & Updates
Is Now An Opportune Moment To Examine Astrana Health, Inc. (NASDAQ:ASTH)?
Dec 12Impressive Earnings May Not Tell The Whole Story For Astrana Health (NASDAQ:ASTH)
Nov 22Astrana Health, Inc.'s (NASDAQ:ASTH) 33% Cheaper Price Remains In Tune With Earnings
Nov 18Recent updates
Is Now An Opportune Moment To Examine Astrana Health, Inc. (NASDAQ:ASTH)?
Dec 12Impressive Earnings May Not Tell The Whole Story For Astrana Health (NASDAQ:ASTH)
Nov 22Astrana Health, Inc.'s (NASDAQ:ASTH) 33% Cheaper Price Remains In Tune With Earnings
Nov 18Here's What Analysts Are Forecasting For Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Results
Nov 10Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce
Oct 04Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?
Sep 26Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business
Sep 12Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?
Aug 28Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors
Aug 02Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?
Jun 19Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal
Jun 02Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 09Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)
Apr 15At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?
Feb 25Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Feb 07Apollo Medical Holdings: Good Company, Not Quite A Hold
Jan 17With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For
Dec 27Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled
Nov 08Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?
Oct 26Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet
Sep 22Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down
Aug 04A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Jul 19We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt
Jun 19Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 05Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?
Apr 20Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Mar 21Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward
Jan 06Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Dec 16Shareholder Returns
ASTH | US Healthcare | US Market | |
---|---|---|---|
7D | -10.4% | -4.1% | -2.4% |
1Y | -11.2% | -10.2% | 23.3% |
Return vs Industry: ASTH matched the US Healthcare industry which returned -10.2% over the past year.
Return vs Market: ASTH underperformed the US Market which returned 23.3% over the past year.
Price Volatility
ASTH volatility | |
---|---|
ASTH Average Weekly Movement | 7.8% |
Healthcare Industry Average Movement | 7.6% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ASTH has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ASTH's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | 1,800 | Brandon Sim | www.astranahealth.com |
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Astrana Health, Inc. Fundamentals Summary
ASTH fundamental statistics | |
---|---|
Market cap | US$1.66b |
Earnings (TTM) | US$62.46m |
Revenue (TTM) | US$1.72b |
26.5x
P/E Ratio1.0x
P/S RatioIs ASTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ASTH income statement (TTM) | |
---|---|
Revenue | US$1.72b |
Cost of Revenue | US$1.46b |
Gross Profit | US$259.89m |
Other Expenses | US$197.43m |
Earnings | US$62.46m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.27 |
Gross Margin | 15.09% |
Net Profit Margin | 3.63% |
Debt/Equity Ratio | 86.4% |
How did ASTH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 01:40 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Astrana Health, Inc. is covered by 13 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Hua Ha | Baird |
Sarah James | Barclays |
Adam Ron | BofA Global Research |